SIMULPHARMA ApS: Financial statements 2018
CVR: 32832075
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 957,772 and a net result of DKK 30,114 compared with DKK 4,808 the year before. That is a decrease of 3% compared with the year before. The profit margin was 3.1%. Equity in the 2018 report amounted to DKK 197,505. The solvency ratio was 85.9%. The company had 1 employee in the financial year.
- Revenue
- DKK 957,772
- Gross Profit
- DKK 955,272
- Profit/Loss
- DKK 30,114
- Equity
- DKK 197,505
- Total Assets
- DKK 229,926
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 958 t. | 955 t. | 30 t. | 198 t. | 1 |
| 2017 | 988 t. | - | 5 t. | 167 t. | 1 |
| 2016 | - | 1.1 mio. | 107 t. | 163 t. | - |
| 2015 | - | 885 t. | 4 t. | 55 t. | - |
| 2014 | - | 774 t. | 426 | 51 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
SIMULPHARMA ApS has published its annual report for 2017. Revenue came to DKK 987,584, and the net result was DKK 4,808.
About SIMULPHARMA ApS
SIMULPHARMA ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company has 1 employee (2018). In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity in the 2024 report amounted to DKK 63,769.